OPKO Health, Inc. (TLV:OPK)

Market Cap	3.55B
Revenue (ttm)	2.60B
Net Income (ttm)	-193.86M
Shares Out	n/a
EPS (ttm)	-0.28
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	807,740
Average Volume	260,542
Open	547.40
Previous Close	563.50
Day's Range	525.50 - 564.90
52-Week Range	427.00 - 734.40
Beta	1.79
RSI	37.96
Earnings Date	May 8, 2025

About OPKO Health

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company’s Diagnostics segment operates BioReference Laboratories that offer laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women’s health, and correctional healthcare to physician offices, clinics, hospitals, employers, ...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2007
• Employees: 2,997
• Stock Exchange: Tel Aviv Stock Exchange
• Ticker Symbol: OPK

Financial Performance

In 2024, OPKO Health's revenue was $713.14 million, a decrease of -17.41% compared to the previous year's $863.50 million. Losses were -$53.22 million, -71.82% less than in 2023.

Financial numbers in USD